title: [Therapy of acute leukemia in adults].
abstract: Treatment of acute leukemias has made a slow but definite progress. About 2/3 of patients with AML und 3/4 of patients with ALL achieve complete remission with cytostatic chemotherapy. However, about 60-70% of patients with ALL and about 50% of patients with ALL relapse usually within the first two years after complete remission. With the introduction of cytokines and differentiating agents into the treatment of leukemia one may expect further improvement of cure rate.
authors.affiliation: Abteilung für Hämatologie und Blutgerinnung der I. Medizinischen Universitätsklinik Wien.
authors.forename: K
authors.initials: K
authors.lastname: Lechner
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D012074:Remission Induction; D015996:Survival Rate
vernacular_title: Therapie der akuten Leukämie des Erwachsenen.